These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15934798)

  • 1. Triptans for migraine therapy: a comparison based on number needed to treat and doses needed to treat.
    Mullins CD; Weis KA; Perfetto EM; Subedi PR; Healey PJ
    J Manag Care Pharm; 2005 Jun; 11(5):394-402. PubMed ID: 15934798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An economic evaluation of triptan products for migraine.
    Perfetto EM; Weis KA; Mullins CD; Subedi P; Healey PJ
    Value Health; 2005; 8(6):647-55. PubMed ID: 16283865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic analysis of triptan therapy for acute migraine: a Medicaid perspective.
    Mullins CD; Subedi PR; Healey PJ; Sanchez RJ
    Pharmacotherapy; 2007 Aug; 27(8):1092-101. PubMed ID: 17655509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.
    McCormack PL; Foster RH
    Pharmacoeconomics; 2005; 23(12):1283-98. PubMed ID: 16336021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of oral triptan therapy for migraine: number needed to treat and relative cost to achieve relief within 2 hours.
    Adelman JU; Belsey J
    J Manag Care Pharm; 2003; 9(1):45-52. PubMed ID: 14613361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of clinical, service, and cost outcomes of a conversion program of sumatriptan to rizatriptan ODT in primary care patients with migraine headaches.
    Gershovich OE; Billups SJ; Delate T; Hoffman CK; Carroll N
    J Manag Care Pharm; 2006 Apr; 12(3):246-53. PubMed ID: 16623609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An economic evaluation of rizatriptan in the treatment of migraine.
    Thompson M; Gawel M; Desjardins B; Ferko N; Grima D
    Pharmacoeconomics; 2005; 23(8):837-50. PubMed ID: 16097844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.
    Ferrari MD; Roon KI; Lipton RB; Goadsby PJ
    Lancet; 2001 Nov; 358(9294):1668-75. PubMed ID: 11728541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eletriptan for acute migraine.
    Smith LA; Oldman AD; McQuay HJ; Moore RA
    Cochrane Database Syst Rev; 2001; (3):CD003224. PubMed ID: 11687056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WITHDRAWN: Eletriptan for acute migraine.
    Smith LA; Oldman AD; McQuay HJ; Moore RA
    Cochrane Database Syst Rev; 2007 Jul; 2001(1):CD003224. PubMed ID: 17636718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eletriptan: a review of its use in the acute treatment of migraine.
    McCormack PL; Keating GM
    Drugs; 2006; 66(8):1129-49. PubMed ID: 16789799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain.
    Pascual J; Fité B; López-Gil A
    Headache; 2002 Feb; 42(2):93-8. PubMed ID: 12005301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using patient-centered endpoints to determine the cost-effectiveness of triptans for acute migraine therapy.
    Kelman L; Von Seggern RL
    Am J Ther; 2006; 13(5):411-7. PubMed ID: 16988536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.
    Ferrari MD; Goadsby PJ; Roon KI; Lipton RB
    Cephalalgia; 2002 Oct; 22(8):633-58. PubMed ID: 12383060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of oral triptan therapy: a trans-national comparison based on a meta-analysis of randomised controlled trials.
    Belsey JD
    Curr Med Res Opin; 2004 May; 20(5):659-69. PubMed ID: 15140331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis.
    Thorlund K; Mills EJ; Wu P; Ramos E; Chatterjee A; Druyts E; Goadsby PJ
    Cephalalgia; 2014 Apr; 34(4):258-67. PubMed ID: 24108308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan.
    Goldstein J; Tiseo PT; Albert KS; Li C; Sikes CR
    Headache; 2006; 46(7):1142-50. PubMed ID: 16866718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Economic evaluation of acute migraine attack treatment with triptans in Spain].
    Gracia-Naya M; Rejas Gutiérrez J; Latorre Jiménez A; González Garcia P
    Neurologia; 2005 Apr; 20(3):121-32. PubMed ID: 15815947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eletriptan review.
    Färkkilä M; Kallela M
    Expert Opin Pharmacother; 2005 Apr; 6(4):625-30. PubMed ID: 15934888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of almotriptan and rizatriptan in the treatment of acute migraine.
    Williams P; Reeder CE
    Clin Ther; 2003 Nov; 25(11):2903-19. PubMed ID: 14693315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.